SCHEMBL8163530

SCHEMBL8163530

CC(=O)N1CC=C(c2ccccc2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NPC1 O15118 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
RAB9A P51151 1/20 0.49
NOTUM Q6P988 2/20 0.48
KCNH2 Q12809 1/20 0.48
HRH3 Q9Y5N1 1/20 0.48
QDPR P09417 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.46
GAA P10253 1/20 0.44
USP2 O75604 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
ALOX12 P18054 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11543936 0.84 QDPR (0.66) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL14262836 0.78 PDK4 (0.56) MAPK1
SCHEMBL21767869 0.75 NAMPT (0.41) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL2241959 0.73 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL4812808 0.73 CNR1 (0.44) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL15140927 0.71 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL10354114 0.71 QDPR (0.44) ALDH1A1KMT2ANPC1RAB9AQDPR
SCHEMBL1193355 0.70 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL28811687 0.70 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL14496802 0.70 QDPR (0.70) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008101665-A1 MACROCYCLIC COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS NOVARTIS AG (CH) 2008-08-28 WO disclosed